Opioid Antagonists and the A118G Polymorphism in the μ-Opioid Receptor Gene: Effects of GSK1521498 and Naltrexone in Healthy Drinkers Stratified by OPRM1 Genotype.

Ziauddeen H.; Nestor LJ.; Subramaniam N.; Dodds C.; Nathan PJ.; Miller SR.; Sarai BK.; Maltby K.; Fernando D.; Warren L.; Hosking LK.; Waterworth D.; Korzeniowska A.; Win B.; Richards DB.; Johnson LV.; Fletcher PC.; Bullmore ET.

Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Opioid Antagonists and the A118G Polymorphism in the μ-Opioid Receptor Gene: Effects of GSK1521498 and Naltrexone in Healthy Drinkers Stratified by OPRM1 Genotype.

Ziauddeen H., Nestor LJ., Subramaniam N., Dodds C., Nathan PJ., Miller SR., Sarai BK., Maltby K., Fernando D., Warren L., Hosking LK., Waterworth D., Korzeniowska A., Win B., Richards DB., Johnson LV., Fletcher PC., Bullmore ET.

This corrects the article DOI: 10.1038/npp.2016.60.

Original publication

DOI

10.1038/npp.2017.287

Type

Journal article

Journal

Neuropsychopharmacology

Publication Date

03/2018

Cookies on this website

Opioid Antagonists and the A118G Polymorphism in the μ-Opioid Receptor Gene: Effects of GSK1521498 and Naltrexone in Healthy Drinkers Stratified by OPRM1 Genotype.

Ziauddeen H., Nestor LJ., Subramaniam N., Dodds C., Nathan PJ., Miller SR., Sarai BK., Maltby K., Fernando D., Warren L., Hosking LK., Waterworth D., Korzeniowska A., Win B., Richards DB., Johnson LV., Fletcher PC., Bullmore ET.

DOI

Type

Journal

Publication Date

Volume